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A human colonic crypt culture system to study regulation of stem cell-driven tissue 
renewal and physiological function 
 
Abstract 
The intestinal epithelium is one of the most rapidly renewing tissues in the human body and 
fulfils vital physiological roles such as barrier function and transport of nutrients and fluid.  
Investigation of gut epithelial physiology in health and disease has been hampered by the lack 
of ex vivo models of the native human intestinal epithelium.  Recently, remarkable progress 
has been made in defining intestinal stem cells and in generating intestinal organoid cultures. 
In parallel, we have developed a 3D culture system of the native human colonic epithelium 
that recapitulates the topological hierarchy of stem cell-driven tissue renewal and permits the 
physiological study of native polarised epithelial cells.  Here we describe methods to 
establish 3D cultures of intact human colonic crypts and conduct real-time imaging of 
intestinal tissue renewal, cellular signalling and physiological function, in conjunction with 
manipulation of gene expression by lentiviral or adenoviral transduction.  Visualisation of 
mRNA- and protein-expression patterns in cultured human colonic crypts, and cross-
validation with crypts derived from fixed mucosal biopsies, is also described.  Alongside 
studies using intestinal organoids, the near-native human colonic crypt culture model will 
help to bridge the gap that exists between investigation of colon cancer cell lines and/or 
animal (tissue) studies, and progression to clinical trials.  To this end, the near native human 
colonic crypt model provides a platform to aid the development of novel strategies for the 
prevention of inflammatory bowel disease and cancer. 
Human Colonic Crypt Culture 
 3 
Key Words: human, intestine, colon, crypt, stem cells, culture, signalling, 
immunocytochemistry, in situ hybridisation, imaging, proliferation, migration, tissue 
renewal. 
1. Introduction 
The human large intestinal epithelium is a monolayer of polarised epithelial cells that is 
exquisitely organised into millions of blind-ending flask-like invaginations called colonic 
crypts (Fig. 1). In the absence of villi (i.e. finger-like protrusions found in the small intestine), 
each colonic crypt is linked to its neighbour by adjoining surface epithelial cells that surround 
the crypt opening.  Approximately 10 billion cells are shed from the gut surface epithelium 
each day. These are continuously replaced by intestinal stem cell progeny that emerge from a 
population of proliferating LGR5/OLFM4-positive stem cells located at the base of each 
colonic crypt[1]. Stem cell progeny (i.e. transit amplifying cells) proliferate, migrate and 
differentiate (into absorptive enterocytes, mucus-secreting goblet cells, hormone-secreting 
enteroendocrine cells and tuft cells that secrete prostaglandins and opioids) along the crypt-
axis before they are shed from the surface epithelium. The prevailing dogma is that a 
hierarchy of rapid tissue renewal (approx. 5-7 days) minimises the life-long accumulation of 
molecular damage and disease risk[2]. Long-lived stem cells are positioned in a relatively 
safe harbour (e.g. sterile) at the crypt-base, from where they fuel the constant replenishment 
of short-lived progeny that migrate up the crypt-axis and differentiate before being shed into 
the gut lumen within a matter of days.  Each crypt houses all of the secretory and absorptive 
cell types that contribute to regular flushing of the crypt lumen (with fluid and mucus 
secretions) and maintenance of barrier function.  As such, individual crypts not only represent 
the self-renewing unit of the tissue, but also fulfil the physiological functions of the intestinal 
epithelium.  
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Isolation of intact colonic crypts has long-held the promise that functional self-renewing units 
of the human intestinal epithelium (i.e. crypts) could be studied ex vivo in real-time when 
placed in 3D culture conditions. Intact colonic crypts can be readily isolated following 
disaggregation of the lamina propria extracellular matrix by chelation of divalent cations or 
enzymatic treatment[3,4].  However, in this configuration, devoid of physical cell-matrix 
interactions, isolated crypts are prone to anoikis[5].  Rescue of isolated crypt viability by 
embedding live crypts in a collagen matrix to restore cell-matrix interactions was an 
important first step towards reconstituting a viable self-renewing crypt culture system[3,6].  
Although we and others demonstrated that embedding colonic crypts in a collagen gel 
maintained crypt morphology, cell polarity and physiological function for a few days[3,7], 
sustained cultured crypt viability required activation of mitogenic signals in combination with 
suppression of anti-proliferative signalling pathways.  The Clevers’ Laboratory paved the 
way by capitalising on their seminal work on Wnt signalling, intestinal stem cells and 
cancer[8-10], and developed the mouse small intestinal organoid culture system[11,12].  This 
‘mini-gut’ culture system formed the basis for the development of human organoid cultures 
from the intestinal epithelium[13,14,1] and from (inducible) pluripotent stem cells[15], both 
of which hold the potential for therapeutic transplantation[16,17].  For the study of native 
intact human colonic crypts, we adopted a similar approach whereby crypts are embedded in 
a basement membrane-derived matrix, Matrigel[18], instead of collagen I[7], and serum-free 
culture  medium is supplemented with the intestinotrophic factors IGF-1 (activator of RAS 
signalling pathway) and R-spondin (activator of Wnt signals) in combination with inhibitors 
of BMP (Noggin or Gremlin proteins) and TGF (SB431542 or A83-01 small molecules) 
signalling pathways[18].  The established human colonic crypt culture system provides a 
Human Colonic Crypt Culture 
 5 
near-native model of a self-renewing tissue unit whereby epithelial cell polarity, tissue 
topology and the hierarchy of stem cell-driven tissue renewal are maintained.  
Two major hall marks of intestinal crypts that are desirable to recapitulate in culture are: (i) 
the hierarchy of crypt cell renewal along the topological axis of the tissue and (ii) functional 
epithelial cell polarity.  Spatial correlation of protein/gene expression patterns with these 
characteristics can give valuable clues about gene function.  Comparison of expression 
patterns in human cultured crypts should be made withcrypts derived from immediately fixed 
colorectal tissue samples for cross-validation of the near-native culture system.  Development 
of a validated near-native colonic crypt culture system ex vivo provides the opportunity to 
gain insights into the regulation of (patho)physiological function.  For example, assessment 
of signalling pathway status in immediately fixed clinical human colorectal tissue samples, 
together with assessment of the effects of pathway activation/inhibition on the processes of 
crypt (stem) cell proliferation, migration and shedding in cultured crypts, demonstrated that 
activation of canonical Wnt signals in combination with suppressed TGF/BMP pathways 
promotes renewal of the native human colonic epithelium[18,19].  Similarly, comparison of 
polarised expression patterns for NKCC1 in immediately fixed clinical human colorectal 
tissue samples with near-native cultured human colonic crypts proved invaluable when 
studying the functional regulation of fluid secretion by calcium-dependent internalisation of 
NKCC1 in native polarised colonic crypt cells[7].  These studies required adaptation of 
standard methods for manipulation of gene expression and assays for signalling pathway 
activation, cell proliferation, migration and shedding so that they may be applied to the 3D 
human colonic crypt culture system.   
The aim of this chapter is to provide protocols not only for human colonic crypt isolation and 
culture, but also for the application of a range of techniques that we have found invaluable to 
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date.  For example, a significant amount of time has been invested in optimising the 
conditions for immunocytochemistry, mRNA in situ hybridisation, and brightfield timelapse 
and fluorescence real-time imaging.  These techniques translate into methodologies to assess 
labelling of markers for intestinal stem cells (e.g. LGR5/ OLFM4), goblet cells (e.g. muc2), 
absorptive enterocytes (e.g. FABP1), tuft cells (e.g. COX1, COX2), enteroendcrine cells (e.g. 
chromogranin A, serotonin), cell signalling pathway status (e.g. beta catenin; phospho-smad 
1,5,8; calcium waves), protein trafficking (e.g. NKCC1 internalisation), crypt cell 
proliferation (e.g. BrDU, Ki67), crypt cell migration (timelapse imaging) and crypt cell 
shedding (timelapse imaging)[7,18].   
 
2. Materials 
1. Human colonic crypt isolation 
1. Dissecting scissors, tissue forceps and knives (25mm blades, Roboz 
RS-6270) 
2. 25ml (Universal) screw top plastic bottles (RL Slaughter, UK) 
3. Crypt isolation buffer: NaCl 140 mM, KCl 5 mM, Hepes (N-2-
hydroxyethylpiperazine-N2-ethanesulphonic acid) 10 mM, d-glucose 
5.5 mM, Na2HPO4 1, EDTA (diaminoethanetetraacetic acid disodium 
salt) 10 mM, dithiothrietol (1 mM), bovine serum albumin (0.1% w/v). 
(All from Sigma, UK) 
4. 25 ml Universal plastic bottle filled with 20 ml AdF12/DMEM culture 
medium (Invitrogen) 
2. Adenoviral and lentiviral transduction [Optional] 
1. Hexadimetherine bromide (#H9268, Sigma, UK; 8 mg/ml stock) 
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2. Adenovirus or lentivirus particles containing, for example, a gene 
reporter (e.g. Wnt reporter, HIV-based, VSV-G; SABiosciences) or 
dominant negative mutant (e.g. adenoviral CMV-DN-TCF4; type 5, 
dE1E3; Vector Biolabs). 
3. Human colonic crypt culture 
1. Matrigel 400 l aliquot (Becton Dickinson, UK; #BD354230) 
2. AdF12/DMEM culture medium (Invitrogen, UK; #12634-028) 
3. Penicillin/Streptomycin (x10000/10000 U/ml; Invitrogen #15140-
122) 
4. Glutamine (x100; Invitrogen; #25030-081) 
5. B27 growth supplement (#12587-010, Invitrogen, UK) 
6. N2 growth supplement (#17502-048, Invitrogen, UK) 
7. N-acetylcysteine (0.5M stock in PBS, Sigma; #A9165-5G ) 
8. Hepes (Invitrogen, #15630-056) 
9. A83-01 (25 mM stock in DMSO; Tocris, UK; #2939) 
10. Human recombinant R-spondin (250 g/ml stock in 0.1% 
BSA/PBS; Sino Biological, China or R&D Systems, UK) 
11. Human recombinant Wnt 3A (100 g/ml stock in 0.1% 
BSA/PBS; R&D Systems) 
12. Human recombinant Noggin (200 g/ml stock in 0.1% 
BSA/PBS; Peprotech, UK) 
13. Human recombinant IGF-1 (100 g/ml stock in 0.1% 
BSA/PBS; Sigma, UK) 
14. Prostaglandin E2 (1 mM stock in DMSO; Caymen Chemicals) 
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15. Formulate 15 mls of human colonic crypt growth medium; 15 
mls AdF12/DMEM, 10 M hepes, 0.5 M A83-01, 100 nM PGE2, 1 
mM n-acetylcysteine, 200 ng/ml human recombinant Noggin, 100 
ng/ml human recombinant Wnt 3A, 500 ng/ml human recombinant R-
spondin-1, 50 ng/ml human recombinant IGF-1.   
16. 4 x 12 well cell culture plates (Nunc multidish, or Corning) or 
glass  bottomed multiwall dish (Mat tek) for timelapse or 
fluorescence  imaging (3.1.4) 
17. Borosilicate glass, zero thickness, 16mm diameter coverslip 
(VWR 631-0151), autoclaved. 
4. Bright field and fluorescence time-lapse imaging 
1. Live cell imaging system including climate control for 
temperature and CO2, automated stage, inverted microscope, 
range of objective lenses, bright field DIC optics and 
fluorescence light source with range of excitation and emission 
filters. We use both Zeiss-Axiovision and Nikon-NIS elements 
based systems for timelapse imaging and a Photon Technology 
Image Ratio Pro system based on a Nikon inverted microscope 
for calcium imaging 
2. Glass bottom mutliwell plate (e.g. Mat Tek) or POC chamber 
(PeCon, Germany) 
3. Hepes-buffered saline (HBS): NaCl 140 mM, KCl 5 mM, 
Hepes (N-2-hydroxyethylpiperazine-N2-ethanesulphonic acid) 
10 mM, D-glucose 5.5 mM, Na2HPO4 1 mM, CaCl2 1mM, 
MgCl2 0.5 mM. 
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4. Fluorescence probes: e.g. Fura2 (calcium-sensitive dye, 1 mM 
stock DMSO; Invitrogen), calcein-AM  (viable cell dye,  5 mM 
stock, Invitrogen) and propidium iodide (dead cell label, 
1mg/ml stock, Invitrogen). 
5. Immunocytochemistry and confocal microscopy 
For 20 coverslips, each with crypts cultured in a polymerised 
droplet of Matrigel, the following will be needed: 
1. Phosphate buffered saline solution (PBS) (100 ml) prepared 
from dissolving 1 tablet (Oxoid BR0014G) per 100 ml de-
ionised water in a re-useable glass bottle. Autoclave before use. 
2. Paraformaldehyde, 4%  (PFA) (10 ml)  in PBS, made by adding 
4 g of PFA powder (Sigma P6148) per 100 ml of previously 
autoclaved PBS or DEPC treated PBS, gently stirred whilst 
warming on a hotplate (covered, in a fume hood) so that the 
temperature never exceeds 65oC until the solution is clear (1-4 
h). It is cooled to 4oC, pH adjusted to 7.4 with 4 M NaOH, and 
aliquotted into 7 ml plastic screw top single use bottles 
("Bijoux" E1412-0711 Starlab) or similar 25 ml bottles 
("Universal", 25 ml, R&D Slaughter code U128) and stored for 
up to 1 month in a -80oC freezer, thawed only immediately 
before use. 
3. TritonX solution, 0.5% (Roche) (10 ml) in PBS prepared 
immediately before use (Caution:light-sensitive). 
4. Ammonium chloride, 100 mM NH4Cl2 (Sigma A9434) (10ml) 
solution in PBS. 
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5. Optional antigen retrieval solution of Sodium dodecyl sulphate 
(SDS, Melford B2008) (5 ml) which is only sparingly soluble in 
aqueous solutions. It is best prepared at least 24 h in advance by 
adding 1% powder to PBS  in a glass bottle and left on a rocker 
overnight until all has dissolved.  It will store for 1 month at 
RT. Alternative antigen retrieval solutions such as 1M HCl in 
PBS (5 ml) or citrate buffer (10 mM tri-sodium citrate (Sigma 
W302600) in water adjusted to pH 6 by addition of HCl) (100 
ml) may be required as specified by antibody suppliers. 
6. Blocking solution (5 ml) prepared up to 1 h before use by 
addition of 1% Bovine serum albumin (BSA) (Sigma A2153) to 
PBS. Optional 10% normal donkey serum (Sigma 9663) and/or 
10% normal goat serum (Abcam Ab7481) can be added, 
depending on the species of secondary antibody to be used. 
7. Coverslip mounting media (200 µl) to prevent photo-bleaching 
(containing nuclear counterstain if required, e.g. propidium 
iodide or DAPI) such as Vectashield™ (Vector labs H1000, 
H1200 or H1300), coated microscope slides (10) (Polysine™ 
VWR), and plain varnish (0.5 ml) (eg. clear nail varnish) to seal 
around edges of coverslips. 
8. Primary antibodies (1-10 µl) suitable for immunofluorescence, 
fluorophore conjugated secondary antibodies (0.5-5 µl). 
 
6. mRNA in situ hybridisation 
1.For 20 coverslips the following are required 
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2.DEPC water or DEPC PBS are used throughout and are made by 
adding 0.1% (1 µl per ml) diethylpyrocarbonate (DEPC, sigma) to 
water (or PBS solution) and left uncovered overnight at room 
temperature (in a fume hood). Next day, cover and autoclave solutions 
to remove the DEPC. 
3.Hybridisation buffer is prepared with 25 ml Formamide, 3.25 ml x20 
SSC pH5, 2.5 ml Chaps (10% or 1 g/10 ml), 1 ml Tween-20 (10%), 0.5 
ml 0.5 M EDTA pH8, 100µl Heparin* (50 mg/ml), 125 µl tRNA&  
(from yeast, 20 mg/ml), make up to 50 ml with DEPC water and store 
at -20oC, only remove from freezer immediately before required. Use 
within 1 month. *Heparin sodium salt from porcine intestinal mucosa 
SIGMA H3149& Yeast type III RNA s.cervisae SIGMA R6750.  
4.Salmon sperm DNA (SS DNA,Sigma D7656) is denatured by 
immersing a 1.7 ml flip top centrifugation tube with the lid covered 
with parafilm containing a small volume (75 µl) SS DNA in a vacuum 
flask containing water heated to 95oC for 5 minutes. The tube is 
removed and allowed to cool (2 minutes) before hybridisation buffer 
and an appropriate concentration of probe is added,(see Note 11 ) and 
pre -warmed for at least 1h at the incubation temperature to be used for 
hybridisation reaction, (Hybridisation mix). 
5.PBST (30 ml ),  0.1% Tween-20 in DEPC treated PBS (0.5ml 10% 
Tween-20 per 500 ml of PBS) 
6.PBST:MeOH (5 ml) , a 50:50 mix of PBST and methanol 
7.HCl-PBST (5 ml) , 1M HCl in PBST 
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8.Make up a fresh stock of Proteinase K (BDH 390923P) in a flip top 
tube by adding 0.005g PK to 0.5 ml DEPC- PBS. From this stock add 
1 µl/ml to DEPC-PBS to make 5 ml Proteinase K working solution. 
9.Hybridisation humidity buffer(20 ml),  formamide and 10% x20 SSC 
(pH5) 
10. x20 SSC , 175.3 g NaCl + 88.2 g Sodium Citrate in 800 ml 
DEPC water pH adjusted  (pH7 with 10N NaOH ,or pH5 1M citric 
acid).  Make up volume to 1 litre, dispense into aliquots and sterilise 
by autoclaving. This stock concentrate can be used to make 
intermediate dilutions such as 5 ml x5 SSC (pH 5) or 5 ml x0.2 SSC 
(pH 5) by dilution with DEPC water. 
7. Double immunocytochemistry and in situ hybridisation 
1.Post-hybridisation blocking solution (5 ml),  2% BBR  blocking 
reagent (Roche 11096176001), 20% normal donkey serum  (Sigma 
D9663) in Tris buffered saline (TBS). 
2.TBS (10 ml), 50 mM Tris-Cl, pH 7.5  150 mM NaCl  , dissolve 6.05 g 
Tris and 8.76 g NaCl in 800 mL of DEPC H2O. Adjust pH to 7.5 with 
1 M HCl and make volume up to 1 L with DEPC H2O. 
3.Normal human serum (40 µl). 
4.Anti-fluroscein primary antibody (5 µl) (Abcam ab 19224), and 1-10µl 
other primary and secondary antibodies suitable for 
immunofluorescence labelling. 
5.Ten coated microscope slides (Polysine™, VWR), 200 µl mounting 
media (Vectashield) and   sealing varnish (1 ml). 
8. Cross-validation with immediately fixed microdissected (MD) crypts 
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Equipment as follows: 
Dissecting microscope with light source (Zeiss Discovery v1.2 
microscope, KL2500 light source, flexible light guide with twin spot 
illuminators)., 
Dissecting stage made from 10 cm disposable petri dish with dark card 
inside and edges sealed with tape 
2 micro-dissecting knives with 25 cm blades (2.1.1) 
Biopsies or surgically obtained mucosal strips as described in crypt 
isolation are fixed immediately on removal from the patient in PFA (4% 
in PBS) at 4oC for 1 hour. The fixed tissue is removed from the PFA and 
left in PBS to wash overnight at 4oC. If tissue is to be used for in-situ it 
is fixed and processed in solutions treated with DEPC and used within 
24 h. For protein localisation tissue can be stored in fridge for up to 7 
days. (see Note 18) 
For 20 coverslips 
1.Small piece of fixed, washed, mucosal tissue 
2.Micro-dissection solution (25 ml) 1mM CaCl2 in PBS.  
3.Hydrophobic barrier pen (e.g. Vector H4000) 
4.TritonX  0.5% in PBS (5ml) 
5. PBS (10 ml) 
6. Matrigel™ thawed on ice (2x 100 µl) 
7.Two 12 well culture plates each with 10 coverslips as described in 
crypt isolation materials, pre warmed in 37oC incubator. 
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8.Two plain glass microscope slides (75 mm x25 x1.5) and two 7 ml 
bijoux bottles. 
 
3. Methods 
3.1. Human colonic crypt isolation 
1. Collect  a 9 cm2 (i.e. 3 cm x 3 cm) piece of mucosa from colorectal surgery 
and cut into 0.5 cm square pieces, or collect 5 x biospy samples from 
endoscopy  (see Note 1).   
2. Remove residual muscularis mucosa with dissecting scissors and forceps and 
discard.   
3. Wash mucosal tissue samples with crypt isolation solution (2.1.3) and place in 
a 20 ml volume contained in a Universal plastic bottle (2.1.2). Incubate at 
room temperature for 90 mins (see Note 2).  
4. Meantime, fill 5 x Universal plastic bottles (2.1.2) with 10 ml of crypt 
isolation solution (2.1.3).  
5. At the end of the 90 min. incubation period (3.1.4), place 5 x tissue biopsy 
samples obtained at endoscopy, or 5 x 0.5 cm square pieces of colorectal 
mucosa derived from surgery (3.1.2), into a Universal bottle pre-filled with 10 
mls of crypt isolation solution (3.1.5).  Shake the solution vigorously to 
liberate whole, intact, isolated crypts (See Notes 3 & 4).  Liberated crypts will 
sediment under gravity to the bottom of the canonical insert of the Universal 
plastic bottle (See Notes 5 and 6).   
6. Carefully remove the remainder of the mucosal tissue samples from the first 
Universal plastic bottle (3.1.6) and transfer them into the second of five 
Universals that have been pre-filled with crypt isolation solution (3.1.5).  
Human Colonic Crypt Culture 
 15 
7. Repeat the process of vigorous shaking, crypt liberation, and sedimentation 
(3.16-3.17) for the remaining four Universal bottles that have been pre-filled 
with crypt isolation solution.   
8. At this stage you will have 5 x Universal plastic bottles each with a pellet of 
isolated crypts at the bottom of the canonical insert.  Collect each pellet of 
crypts with a 200 l pipette and tip and place into a single Universal plastic 
bottle filled with 20 ml of ice-cold AdF12/DMEM (2.1.4). Crypts will 
sediment under gravity and form a pellet (see Note 6).  
9. Repeat steps 3.1.6-3.1.10 until crypts cease to be liberated from mucosal tissue 
samples 
10. Remove AdF12/DMEM supernatant from accumulated pellet of isolated 
crypts (3.1.9) and adjust volume of residual crypt suspension to a density of 
500 crypts/100 l AdF12/DMEM 
3.2.Adenoviral and lentiviral transduction [optional] 
1. Incubate isolated crypt suspension (3.1.11) on ice for 15 minutes with 
hexadimetherine (8 g/ml) and the desired adenovirus or lentivirus vector (e.g. 
2.2) at a multiplicity of infection of 250 x 103 TU/crypt.  
3.3. Human colonic crypt culture 
1. Prepare 15 mls of human colonic crypt growth medium in advance of the 
isolation (2.3.15). 
2. Thaw a 400 l frozen aliquot of Matrigel on ice for 30 mins (2.3.1). 
3. Add 1 ml of PBS to the corner wells of each 12 well plate (2.3.12) and add one 
glass coverslip (2.2.13) to the remaining 8 wells of each 12-well plate. Pre-
warm 12 well plates at 37oC for 30 mins (see Note 8). 
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4. Take 100 l of isolated crypt suspension (2.1.11) and add to thawed 400 l 
aliquot of Matrigel on ice and mix carefully. 
5. Dispense 20l of isolated crypt/Matrigel suspension (3.3.3) on to each 
coverslip and return 4 x 12 well plates to 37oC incubator for 15 min. until 
Matrigel has polymerised. 
6. Remove from incubator and flood polymerised Matrigel/crypt droplet with 400 
l of human colonic crypt culture medium; return to incubator  
7. Change culture medium every other day. A typical field of view and 
appearance of crypt morphology following 7 days in culture is shown in Fig. 2. 
8. Matrigel will destabilise progressively in colonic crypt culture. Cultured crypts 
will need re-plating into a fresh Matrigel droplet every week.  Crypts can be 
liberated by incubation in crypt isolation buffer (2.1.3) for 20 mins on ice 
followed by mechanical agitation with a 1 ml pipette and tip.  Liberated crypts 
should be collected by sedimentation in AdF12/DMEM and re-suspended into 
fresh Matrigel as above (see Note 9) 
 
3.4. Real-time bright field and fluorescence imaging 
1. Mount single glass coverslips into POC chamber or use crypts that have 
been seeded onto a multiwell plate with glass bottom (2.4.2). 
2. To monitor crypt cell morphology, proliferation and migration in real-
time, place multiwell plate into climate controlled chamber (5% CO2, 
37oC) located on stage of inverted microscope and establish DIC 
illumination with a x20 objective (Note 10) 
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3. Crypt cell proliferation, migration and shedding along the crypt-axis are 
optimally observed by taking an image every 5 minutes for the duration of 
the experiment[18] (see Fig. 3 for an example of crypt cell proliferation) 
4. To monitor crypt cell volume[7] or viability[18], load crypts with calcein-
AM (5 M) for one hour, wash twice with HBS (2.4.3). Excite at 488 nm 
and visualise emission at 520 nm.   
5. To monitor crypt cell viability, incubate crypts with propidium iodide (1 
g/ml) which will fluoresce when it binds to the nuclei of cells that have 
lost the plasma membrane integrity.  Excite propidium iodide at 488 nm 
and visualise emission at 620 nm.  Fig. 4 illustrates the live/dead (i.e. 
calcein/propidium iodide) labelling pattern of a human colonic crypt[18]. 
6. To monitor intracellular calcium signals, load crypts with Fura2-AM (5 
M) for one hour.  Wash crypts with HBS and excite alternately with 340 
nm and 380 nm. Intracellular calcium signals are visualised by monitoring 
the ratio of fluorescence emitted at 510 nm following excitation by 340 nm 
and 380 nm. Fig. 5 illustrates a calcium signal invoked in the stem cell 
niche at the crypt base by stimulation of muscarinic acetylcholine 
receptors[7].   
3.5. Immunocytochemistry 
1. Select isolated, cultured crypts (in Matrigel affixed to glass coverslips) and if 
required stimulate with agonists or inhibitors and/or incubate with BrDU (10 
M). Alternatively prepare MD crypts (3.8). Leave coverslips in the culture 
dish. 
2. Aspirate off any culture medium and add sufficient 4%PFA in PBS to cover 
each Matrigel (200 µl).  
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3. Aspirate off fixative, pipette on sufficient PBS to cover Matrigel as a wash, 
remove by aspirating and repeat. 
4. Permeabalise crypts by covering in TritonX solution (omit for MD). Leave for 
30 minutes. 
5. Remove TritonX and wash twice in PBS (as 3 above). 
6. Reduce cross linking of protein by adding ammonium chloride (NH4Cl2) 
solution for 13 minutes. 
7. Remove ammonium chloride and wash twice in PBS (as 3 above). 
8. An optional step can be included here to improve epitope retrieval by addition 
of SDS solution, 1M HCl solution (BrdU antigen), or by boiling the coverslips 
in citrate buffer for 5-10 minutes, as appropriate to the primary antibody to be 
used. 
9. Wash twice in PBS if antigen retrieval step used. 
10. Discourage non-specific antigen binding by blocking with 1% BSA solution 
(with optional 10% normal goat and/or donkey serum) for 2h. 
11. Prepare primary antibodies by diluting according to suppliers instructions 
(range 1:25 to 1:500 usually) in PBS. 
12.  Remove block by aspirating but do not wash, add 20 µl of antibody per 
coverslip. Wrap culture dish in film to reduce evaporation loss and leave on 
for 12-24h. 
13. Prepare (flurophore-conjugated) secondary antibody according to suppliers 
instructions (usually at half the concentration that the primary was used at) in 
PBS. 
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14. Remove primary antibody by adding 200 µl per coverslip of PBS and then 
aspirating off. Wash second time in PBS, remove and add 20 µl per coverslip 
of secondary antibody mix. 
15. Leave secondary antibodies on for 2h, preventing dish from exposure to 
ambient or artificial light by covering with foil or light-proof plastic box to 
avoid bleaching of flurophore. 
16. Remove secondary antibodies as in 13 above, leave in PBS wash for 1h. 
17. Lift out coverslips from dish, clean back surface with ethanol on a tissue add a 
drop of mounting media and invert the coverslip onto a coated microscope 
slide. Seal around edges of coverslip with a transparent varnish and store in a 
light proof box prior to imaging by confocal microscopy (see Fig. 6). 
3.6. mRNA in situ hybridisation 
1. For 20 coverslips cultured or MD crypts 
2. Fix crypts on coverslips for 30 minutes in PFA (200uL per well) leaving them 
in the 12 well culture dish (see Note 12). 
3. Whilst fixing prepare and pre-warm hybridisation mix in hybridisation oven 
4. Aspirate off fixative and re-cover the crypts with PBST to wash. Remove, 
repeat wash.  
5. Add PBST-MeOH so that each coverslip is covered for no more than 30 
seconds, aspirate off, immediately replace with HCl-PBST (without wash), 
and leave on for 5 minutes. 
6. Remove HCl-PBST and wash twice.  
7. Add Proteinase-K solution for 10 minutes, remove and replace with PFA for 
10 minutes.  
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8. Remove fixative and wash twice. Remove as much of PBST as possible with 
aspirator and then leave coverslips uncovered to dehydrate on bench for 1h. 
9. After dehydration add 75uL per coverslip of warm hybridisation mix, cover 
plate and wrap in tissue soaked in hybridisation humidity buffer (see Note 13).  
10. Put plates into hybridisation oven at chosen temperature for 12-16 hours. 
11. Remove one plate from the oven, add 200 l x5 SSC re-cover and replace in 
oven for 5 minutes, repeat with other plate. (see Note 14) 
12. Remove plate(s) from oven and aspirate off SSC, replace with 200uL x0.2 
SSC and leave on bench for 1h (see Note 15). 
13. At this stage coverslips can be removed from dish and mounted on a slide for 
imaging as described in (3.5.17), however FAM labelled probes are prone to 
rapid photobleaching under a confocal microscope and it is advantageous to 
perform double immunocytochemistry and in-situ additional steps to label the 
hybridised mRNA with a more photo-stable fluorescent conjugated secondary 
antibody and simultaneous labelling of other proteins of interest.. 
 
7. Double immunocytochemistry and in situ hybridisation 
1. To coverslips that have reached stage 12 of in-situ protocol (3.6.12) remove 
x0.2 SSC from crypts and place in post-hybridisation blocking solution for 90 
minutes. During the blocking time prepare the anti-FAM primary antibody by 
pre-absorbing it in normal human serum (10 µl serum per 1 µl antibody) at 
room temperature for 1hour and 37oC (waterbath) for 30 minutes (see Note 
16). 
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2. Allow pre-absorbed primary antibody mix to cool, add other primary 
antibodies (if required) and make up volume with TBS and 2% normal donkey 
serum to desired final concentration (see Note 17). 
3. Aspirate off block and add 20 µl of antibody/serum/TBS cocktail to each 
coverslip. Wrap (3.5.12) and leave for 20-24h at room temperature. 
4. Add 200 µl TBS to each coverslip, aspirate off. Repeat wash. Add secondary 
antibody made up in TBS. Protect from light and incubate for 2h at room 
temperature. Repeat TBS wash and leave in TBS for 1h. Mount up coverslips 
(3.5.17) and image with a confocal microscope (see Fig. 6). 
8. Cross-validation with immediately fixed microdissected (MD) crypts 
1. A hydrophobic barrier pen is used to draw a rectangle about 1 cm by 2 cm on 
a plain glass slide and filled with dissection solution with so that a flattened 
dome forms (200-400 µl). The coverslip is positioned on a stage under a 
dissecting microscope (see Note 19) 
2. A 1 mm square section of the fixed tissue is cut under the microscope and is 
then reduced to individual, intact, epithelial crypts by teasing them apart from 
the underlaying fibroblasts using a pair of micro dissecting knives. 
3. When 5-10 individual crypts have been teased off it is advantageous to remove 
them from the coverslip for safe-keeping using 1 ml pipette tip to aspirate 
them. Transfer to a 7ml bijoux on ice. The dome of dissection solution is 
replenished, and more individual crypts teased from the biopsy. 
4. Repeat until at least 200 crypts have been obtained. 
5. Dissected crypts are permeabalised for 1 h in a 0.5% solution of TritonX 
(Roche) in PBS at 4oC and then washed by replacing the solution with PBS 
twice. 
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6. About 100 of the Individual crypts should be picked up using a 200 µl pipette 
and placed into a 100 µl aliquot of Matrigel that has been thawed on ice (see 
Note 20). 
7. A 10 µl drop of Matrigel is placed on each coverslip (in a 12 well culture dish) 
and put for 30 minutes in 37oC incubator to set the Matrigel. (see Note 21) 
 
 
4. Notes 
1. Obtain ethical approval and informed consent for collection of mucosal tissue samples 
from colorectal surgery or from recto/sigmoid endoscopy for research purposes.   
2. The crypt isolation solution is devoid of calcium and magnesium which will serve to 
disaggregate the extracellular matrix proteins that secure the crypts in the lamina 
propria.   
3. The vigour with which mucosal tissue samples are shaken at the end of the incubation 
period for isolation needs to be optimised in an empirical fashion so as to liberate 
single intact crypts or small groups of intact crypts that are not fragmented.   
4. Crypt liberation will depend on the efficiency with which the calcium-/magnesium-
free crypt isolation solution causes (i) disaggregation of the extracellular proteins of 
the lamina propia, within which the crypts are embedded, and (ii) DTT-mediated lysis 
of extracellular mucus, which can form a barrier between the tissue samples and the 
crypt isolation solution. The incubation time in the crypt isolation solution may need 
to be extended if the crypts are slow to liberate. 
5. 0.1% BSA contained within the crypt isolation solution (2.1.2) increases the specific 
gravity such that liberated crypts sediment to the bottom of Universal plastic bottles 
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under gravity, whereas single contaminating mesenchymal cells such as 
myofibroblasts and lymphocytes do not.   
6. Centrifugation is not recommended as it increases the likelihood of disrupting the 
integrity of liberated intact whole colonic crypts. 
7. As pointed out previously[12], crypt viability is compromised by prolonged exposure 
to EDTA 
8. Filling of peripheral wells with PBS and in-filling between wells with PBS will help 
prevent evaporation of culture medium  
9. Crypt viability can be maintained for up to one month, but there is an increasing 
propensity for organoid formation[13] 
10. Plastic dishes/lids interfere with DIC optics 
11. Design and synthesise oligonucleotide probes with at least two 5/6-
carboxyfluorescein succinimidyl ester (5/6FAM) molecules at 5'and 3' ends for the 
target mRNA (This protocol was developed using Exiqon Custom LN™ detection 
probes with 20mer sequence flanked by 5/6FAM molecules at 5' and 3' ends). 
Scrambled probes should be used as a negative control.  A positive control probe for a 
ubiquitously expressed gene such as beta actin should also be used[18]. 
12. Calculate and ensure enough reagents are available for protocol, some reagents are 
best made shortly before using so whilst crypts are fixing, prepare reagents for next 
steps in protocol e.g. Proteinase K, denatured Salmon sperm DNA (SS DNA Sigma 
D7656) and add 2 µl probe (probe concentration in range 10-75 nM) to 1433 µl 
hybridisation buffer and 75 µl SS DNA in 1.7 ml flip top centrifuge tube and place 
mix in hybridisation oven to warm (approx 90 min) to make hybridisation mix. PBS-
MeOH is also best used freshly prepared. 
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13. Once the hybridisation mix has been added it is vital now that the coverslips never dry 
out again, so carefully wrap plate in an absorbent cloth soaked in formamide/x4 SSC  
solution and then  over-wrapped with plastic film such as catering cling-film. Place in 
hybridisation oven (at temperature depending on probe but in range 40-70oC) for at 
least 12 h (up to 16 h determined by experiment). 
14. Remove one plate at a time from the oven, unwrap but do not discard) and add 200 µl 
of x5 SSC to each coverslip (there will not be sufficient probe remaining to aspirate), 
wrap up to prevent dessication and return to the oven (bottom shelf) for 5 minutes. 
15. Remove from oven, remove and discard wrapping, aspirate off x5 SSC and replace 
with sufficient x0.2 SSC to cover crypts and leave for 1 hour at room temperature. If 
double immunocytochemistry and  in-situ  is attempted then the following steps in 
protocol prepare the hybridised crypts for the addition of primary antibodies. 
16. It is essential that no phosphate containing buffers are used from here as it may 
interfere with the hybridised probe, only use TBS . 
17. The addition of  2% donkey serum  to block is to reduce non-specific binding when 
donkey fluorescence conjugated secondary antibodies are used (or substitute relevant 
secondary antibody species). 
18. If MD crypts are to be used for in-situ hybridisation then all solutions must be made 
with DEPC treated water, and particular attention paid to cleaning instruments and 
surfaces to avoid dnase contamination 
19. Twin spot light sources of the dissecting microscope should be adjusted so that a near 
horizontal  beam of light falls on the specimen from either side. Correct positioning of 
the light source aids depth perception of the specimen when dissecting. 
20. The minimum amount of fluid should be taken up with the crypts to avoid excessive 
dilution of the Matrigel. Gravity sedimentation of crypts is preferable to pelleting by 
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centrifugation as the latter can cause clumping of the dissected and permeabalised 
crypts when resuspending in Matrigel. 
21. When the Matrigel has set crypts can be covered with 200 µl per well of PBS and 
stored at 37oC for 1 day, or fixed in PFA for immediate processing for 
Immunocytochemistry or in-situ hybridisation 
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Figure legends 
Figure 1: Hierarchy of stem cell-driven renewal of the human colonic epithelium. The 
human colonic crypt base contains a mixture of proliferating stem cells, mitotic progenitor 
cells, and post-mitotic differentiated cells.  Cells in the upper half of the crypt are mostly 
post-mitotic and migrate in an upward direction to the surface epithelium . On reaching this 
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destination they are shed into the crypt lumen .  These cells are replaced by stem cell progeny 
that emanate from the stem cell niche and differentiate en route to the surface epithelium. 
 
Figure 2: Human colonic crypt culture.  (a) & (b) A typical field of view for  human 
colonic crypts following 7 days in culture.  Open arrowheads indicate crypt bases and filled 
arrowheads indicate accumulation of shed cells at the crypt opening.  (c) higher magnification  
view of crypts over 4 days and 7 days of culture.  (Adapted from Ref. 18) 
 
Figure 3: Real-time imaging of crypt cell division. DIC imaging of cell nucleus migration 
from the basal pole to the apical pole(20 min.) followed by cytokinesis (35 min.) and return 
of daughter cell nuclei to the basal pole (75 min.).   
 
Figure 4: Hierarchy of calcein-labelled live cells and propidium iodide (PI)-positive 
dead cells.  The number of PI-positive shed cells increases over time in culture. (Adapted 
from Ref. 18) 
 
Figure 5: Live cell imaging of calcium signalling along the colonic crypt-axis.  Fura2 
loaded crypts were stimulated with acetylcholine (10 M). The F340/F380 pseudocolour 
ratio images demonstrate that acetylcholine induces a calcium signal in the stem cell niche 
which propagates along the crypt-axis with respect to time.  (Adapted from Ref. 7) 
 
Figure 6: Labelling human intestinal stem/progenitor cells.  Stem cell markers LGR5 and 
OLFM4 were labelled in native human colonic crypts micro-dissected from a fixed biopsy 
specimen.  Microdissected crypts were subjected to either immunocytochemistry for LGR5 
(Origene mouse monoclonal antibody clone 2A2) and OLFM4 (Abcam rabbit polyclonal 
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antibody) or double LGR5 mRNA in situ hybridisation and OLFM4 immunocytochemistry. 
Similar observations were made for cultured crypts[18]. 
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